Share on Pinterest Bariatric surgery may be better for preserving kidney function in people with diabetes and obesity than GLP-1 drugs. Image credit: Ruben Earth/Getty Images. In a new study ...

A real-world study of veterans with type 2 diabetes finds better kidney outcomes over 3 years with use of SGLT2i vs GLP1RA. The risk for kidney function decline is lower among new users of sodium ...

In the nonsurgical group, the most common GLP-1 medications were liraglutide and ... Researchers found that bariatric surgery ...

GLP-1: Glucagon-like peptide-1; RA: receptor agonist. ACS: Acute coronary syndrome; CAD: Coronary artery disease; CHF: Congestive heart failure; CRF: Chronic renal ...

Medications like Ozempic and Wegovy are famous for their weight loss benefits, but some scientists want to know more about ...

Fasting-Mimicking Diet May Restore Kidney Function A dietary intervention restored ... treatments have a known AKI risk, exposure to GLP-1 receptor agonist drugs shows no added risk.

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier (the filter that protects the brain from harmful substances), experiments ...

Research highlights how GLP-1 receptor agonists may improve brain health by targeting the neurovascular unit, linking metabolic health to cognitive function. It suggests potential therapies for ...

Drugs that belong to the class of GLP-1 receptor agonists could cause muscle loss ... Users have reported improvements in ...

New research reveals how GLP-1 receptor drugs, known for treating diabetes and obesity, also protect the brain’s vital ...

In a new study, people with obesity, diabetes, and chronic kidney disease were less likely to see their kidney disease advance after bariatric surgery compared to people treated with GLP-1 drugs.